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Lost in translation: the signal hypothesis
 
t was cell biology’s version of the ship
in the bottle. How do proteins a cell
intends to secrete end up in the endo-
plasmic reticulum? Winkling out the details
of the translocation mechanism that spirits
these proteins into the ER required more
than 20 years and earned Günter Blobel of
Rockefeller University the 1999 Nobel
Prize in Physiology or Medicine.
Another Rockefeller laureate, George
Palade, had demonstrated that ribosomes
free in the cytoplasm manufactured non-
secreted proteins, whereas ribosomes stuck
to the ER made proteins for export. Cell
biologists searched in vain for distinctions
between free and attached ribosomes that
might explain their contrasting behavior. A
new assistant professor at Rockefeller and
Palade’s protege, Blobel suspected that the
difference must lie in the proteins them-
selves. He and colleague David Sabatini
conjectured that secretory proteins might
carry a short segment near the NH
 
2
 
 terminus
(Blobel and Sabatini, 1971). Once this
sequence protruded from the ribosome
during translation, a “binding factor” would
hook onto the protein and guide it and the
ribosome to the ER membrane. Continued
translation would then thread the elongating
protein into the ER’s interior. “It was a
beautiful idea,” says Blobel. It was also, he
admits, “pure speculation.”
But it didn’t take long for evidence of
a “signal sequence” to start accruing. The
cell-free translation system concocted by
Philip Leder and colleagues (Swan et al.,
1972) churned out an antibody light chain
that was 6 to 8 amino acids longer than
the normal secreted version in the body.
Tonegawa and Baldi (1973) and Schechter
(1973) obtained similar results.
Unaware of Blobel and Sabatini’s
hypothesis, Cesar Milstein of Cambridge
University proposed a similar idea based
on his team’s cell-free system. It also
I
The signal hypothesis in 1975, with the signal 
peptide as a dotted line.
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pumped out an overweight light chain, but
when the researchers checked the output
of microsomes (ER fragments), they
found only the normal-sized protein
(Milstein et al., 1972). Milstein speculated
that the extra amino acids help direct the
growing protein to the ER.
Despite this suggestive data, detrac-
tors argued that the protein’s extra heft
was an artifact of in vitro translation or
isolation errors, Blobel recalls. To answer
their complaints, he crafted a protein-
synthesizing system with help from post-doc
Bernhard Dobberstein (now at the Univer-
sity of Heidelberg). Using detergent, they
dislodged ribosomes from rough micro-
somes, and then slipped the particles—
which carried unfinished light chains—
into a solution that allowed protein making
to resume. Because the researchers also
added a compound that blocks new trans-
lation, the ribosomes could only complete
chains they had started.
At first, only the smaller, processed
chain appeared (Blobel and Dobberstein,
1975a). These proteins came from ribo-
somes that were well into translation
when they parted from microsomes, the
researchers concluded, and the chains
they held had already undergone pruning
to remove the signal sequence. After a
few minutes, however, the synthesis mix-
ture started producing longer chains as
well. The bulkier proteins emerged from
ribosomes that had just started translating
when isolated from microsomes. At the
time, they bore stubby chains that hadn’t
yet shed their signal sequence. When
translation restarted, these short chains
didn’t lose the sequence—evidence that
the processing enzyme that removes the
signal is part of the ER membrane.
In another key experiment, Blobel
and Dobberstein let rough microsomes—
which carry ribosomes and some associ-
ated mRNA—produce proteins.
The scientists detected only the
shorter version. Adding the
protein-dissolving enzymes trypsin
and chymotrypsin (which rarely
enter the microsomes) did not digest
most of the chains, confirming that the
trimmed protein ends up tucked away
within the microsomes, as the signal hy-
setbacks, Blobel was “prepared for failure”
when he tried microsomes from dog
pancreas. Instead, in December of 1974,
the procedure finally worked.
The pair quickly showed (Blobel and
Dobberstein, 1975b) that this combination
produced mostly the short form of the light
chain. If primed with the right mRNA, the
system would also make globin, a non-
secreted protein. Unlike the processed light
chain, globin fell victim to the protein-
dissolving enzymes, indicating that it didn’t
slip into the microsomes. Moreover, if
complete, oversized light chains were added
after the microsomes, they didn’t lose the
signal sequence, verifying that the removal
of the segment occurs during translation,
not afterwards. That their Rube Goldberg
concoction of mouse RNA, rabbit ribo-
somes, and dog ER actually synthesized
proteins demonstrated something else,
Blobel says. “[It] had the virtue of showing
that this is a universal system.” 
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Ribosomes severed from microsomes make first 
a smaller, processed protein (left) and later a 
longer form with signal sequence intact (upper 
band on right).
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pothesis predicted.
The next goal, Blobel recalls, was
to build the “translation-translocation”
mechanism from scratch, using isolated
mRNA, small and large ribosome units,
and microsomes. But the work stalled.
No matter what animal the microsomes
came from, they always stifled translation
in the cell-free system. After numerous
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homas Stossel was lucky he didn’t
know how difficult phagocytosis
would be to figure out. “If I’d
known how complicated it was, I might
have gone another way,” he says. In the
18th century, some of the first observations
with optical microscopes had shown that
cells engulf food and slither along by turn-
ing part of their cytoplasm into a semi-solid
gel, and then liquefying it again. Stossel
and his colleague John Hartwig (both at
T
Gelled macrophage supernate sticks to the top 
of an inverted tube (left).
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Harvard University) wanted to know what
controlled this gel–sol transformation.
At the time, the discovery that non-
muscle cells contained actin and myosin
was fresh. But what the pushy proteins
accomplished was uncertain—researchers
had just discerned that actin helps form
the contractile ring that pinches cells in
half during division (Schroeder, 1972).
Stossel and Hartwig started by nabbing
a new molecule they called actin-binding
protein—the very first actin-binding
protein—that spurred actin fibers in vitro
to coalesce into a mesh (Hartwig and
Stossel, 1975). This mesh later turned out
to provide a substrate for myosin-mediated
contraction.
Next, Stossel and Hartwig (1976)
reproduced this phenomenon with puri-
fied proteins and linked the process with
what was happening in vivo during
phagocytosis. They showed that extracts
of macrophages in the midst of phagocy-
tosis solidified into a gel and did so faster
than did those from cells that weren’t
eating. What’s more, cytoplasm from
cells that had recently swallowed an oil
droplet contained more actin-binding
protein than did material from resting
cells. A mixture of actin, myosin, and
actin-binding protein, but not the duo of
actin and myosin alone, would also gel.
The idea that actin molecules can’t
knit into a gel without help from actin-
binding protein was controversial, Stossel
recalls. In fact, the preceding paper in the
same issue argued the opposite view
(Pollard, 1976). Stossel says that it took
about 15 years to win over most doubt-
ers, and during this time the number of
participating molecules swelled. For ex-
ample, Stossel’s lab discovered a protein
called gelsolin, which unhooks actin fila-
ments (Yin and Stossel, 1979). Gelsolin
and the original actin-binding protein,
now called filamin A, are two of the hun-
dreds of molecules that help orchestrate
cell movements. 
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EGF is internalized and degraded
 
hirty years ago, cell biologists were convinced that
protein hormones and cells had a superficial relationship.
Although steroid hormones such as testosterone could
squeeze through the cell membrane to deliver commands, their
protein counterparts never got beyond receptors on the cell’s
surface. Graham Carpenter and Stanley Cohen (both then at
Vanderbilt University) overturned the conventional wisdom with
their study of epidermal growth factor (EGF), a protein hormone
that spurs fibroblasts to duplicate their DNA and divide.
When the pair steeped human fibroblasts in EGF tagged with
radioactive iodine, they found that the amount of radioactivity
affixed to the cell’s surface peaked after 
 
 
 
30 to 40 min, and then
plummeted (Carpenter and Cohen, 1976). To track the missing
radioactivity, Carpenter and Cohen soaked cells in labeled EGF
before shifting them to a hormone-free mixture. The hot iodine
returned to solution, the researchers discovered, but not as part of
EGF. Almost all of it had transformed into monoiodotyrosine and
diiodotyrosine, breakdown products of EGF. That finding provided
strong circumstantial evidence that after EGF binds to a receptor,
cells take in the hormone, chop it up, and eject the fragments.
To bolster that conclusion, the team added antibodies that tar-
get EGF to a solution of cells bathed in the hormone. The longer the
experiment ran, the fewer antibodies attached to the cells, implying
that EGF was vanishing from the plasma membrane. Carpenter and
Cohen’s results suggested the hormone was ending up in the lyso-
somes for demolition. When they combined EGF-laden cells with
T
Labeled EGF binds to cells 
but is then taken up and 
degraded.
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chloroquine, which hinders the or-
ganelle’s protein-slicing enzymes, the
breakdown of EGF slowed. “The key
experiment was showing that lyso-
somal inhibitors prevented degradation
[of the hormone],” says Carpenter.
The findings supported the no-
tion that the hormone’s receptors are
“swallowed” and replaced by fresh
proteins—an inference later studies
substantiated. The team determined
that cells required 10 h to regain their
full EGF-binding capacity. But the recovery stagnated if the
researchers mixed in molecules that inhibit protein or RNA
synthesis. Further work showed that cells absorbed and pro-
cessed more than just protein hormones. For example, research
led by Nobel laureates Michael Brown and Joseph Goldstein
demonstrated that cells also engulf low-density lipoproteins and
recycle the receptors (Anderson et al., 1976, 1977, 1982). And
multiple studies in recent years have emphasized that a lot of
signaling occurs even after uptake of receptors into cells. 
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